U.S. Short-read Sequencing Market Size & Outlook
U.S. short-read sequencing market, 2018-2030 (US$M)
Related Markets
U.S. short-read sequencing market highlights
- The U.S. short-read sequencing market generated a revenue of USD 2,614.9 million in 2023 and is expected to reach USD 8,536.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 18.4% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Short-read sequencing market data book summary
| Market revenue in 2023 | USD 2,614.9 million |
| Market revenue in 2030 | USD 8,536.2 million |
| Growth rate | 18.4% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Services |
| Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Birks Group Inc Class A, Qiagen NV, Agilent Technologies Inc, Macrogenics Inc, Azenta Inc, PerkinElmer, ProPhase Labs Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 45.9% of the global short-read sequencing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. short-read sequencing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 914.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Short-read Sequencing Market Scope
Short-read Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. short-read sequencing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to short-read sequencing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 62.68% in 2023. Horizon Databook has segmented the U.S. short-read sequencing market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
The short read sequencing market in U.S. is expected to grow significantly in the near future owing to recent progress in the status of molecular biology techniques within the country. The highest amount of clinical development of sequencing platforms for application in oncology and infectious diseases is taking place in the U.S.
In addition, presence of market-leading firms such as Illumina, Roche, and Life Technologies also enhances the market position of U.S. These players are involved in development and introduction of rapid and high throughput sequencing platforms that keep the U.S. at the forefront of short read sequencing market.
Reasons to subscribe to U.S. short-read sequencing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. short-read sequencing market databook
-
Our clientele includes a mix of short-read sequencing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. short-read sequencing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. short-read sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. short-read sequencing market size, by product, 2018-2030 (US$M)
U.S. Short-read Sequencing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
